Bifidobacterium longum subsp. longum

Bifidobacterium longum subsp. longum is a probiotic strain that produces short-chain fatty acids like acetate and lactate to maintain gut barrier integrity. It modulates immune function through interaction with intestinal epithelial cells and dendritic cells, reducing inflammatory cytokines.

Origin & History

Bifidobacterium longum subsp. longum is a well-studied probiotic strain found in the human gut. It is known for its significant role in maintaining digestive health.

Historical & Cultural Context

Bifidobacterium longum subsp. longum has been used in fermented foods globally, valued for its health-promoting properties.

Health Benefits

- Supports a healthy and balanced gut microbiome by promoting the growth of beneficial bacteria, enhancing digestion. - Enhances immune system function by increasing the production of protective cytokines, reducing infection risk. - Reduces symptoms of allergies by modulating immune responses, leading to decreased allergic reactions. - Aids in lowering cholesterol levels by fermenting fibers into short-chain fatty acids, promoting heart health. - Contributes to weight management by regulating appetite hormones, helping maintain a healthy weight. - Improves mental well-being by producing GABA, a neurotransmitter that reduces anxiety. - Supports skin health by reducing inflammation, promoting a youthful appearance.

How It Works

B. longum produces acetate, lactate, and propionate through carbohydrate fermentation, which lower intestinal pH and inhibit pathogenic bacteria. The strain adheres to intestinal epithelial cells via surface proteins and stimulates regulatory T-cell production while modulating NF-κB signaling pathways. It enhances tight junction proteins like claudin-1 and occludin to strengthen intestinal barrier function.

Scientific Research

Numerous studies support the role of Bifidobacterium longum subsp. longum in digestive and immune health, making it one of the most researched probiotics.

Clinical Summary

Human studies with B. longum typically use doses of 1-10 billion CFU daily for 4-12 weeks. Randomized controlled trials show significant improvements in IBS symptoms, with 60-70% of participants reporting reduced abdominal pain and improved stool consistency. Clinical evidence demonstrates enhanced immune markers including increased IgA production and reduced inflammatory cytokines IL-6 and TNF-α. Most studies involve small to moderate sample sizes (30-200 participants), with stronger evidence needed for long-term effects.

Nutritional Profile

- Contains live probiotic cultures. - Produces lactic acid, supporting gut health. - Low in calories.

Preparation & Dosage

Available in probiotic supplements and some fermented foods. Dosage varies; consult a healthcare provider.

Synergy & Pairings

Inulin, Fructooligosaccharides, Lactobacillus acidophilus

Safety & Interactions

B. longum is generally well-tolerated with mild gastrointestinal symptoms like bloating or gas occurring in fewer than 5% of users during initial weeks. No significant drug interactions are documented, though it may theoretically affect absorption of medications requiring specific pH conditions. Immunocompromised individuals should consult healthcare providers due to rare cases of probiotic bacteremia. Safety during pregnancy and breastfeeding appears favorable based on limited studies, but medical supervision is recommended.